Načítá se...
Therapeutic potential of nuclear receptor agonists in Alzheimer’s disease
Alzheimer’s disease (AD) is characterized by an extensive accumulation of amyloid-β (Aβ) peptide, which triggers a set of deleterious processes, including synaptic dysfunction, inflammation, and neuronal injury, leading to neuronal loss and cognitive impairment. A large body of evidence supports tha...
Uloženo v:
| Vydáno v: | J Lipid Res |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The American Society for Biochemistry and Molecular Biology
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5625128/ https://ncbi.nlm.nih.gov/pubmed/28264880 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.R075556 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|